ARCH Venture Management as of Dec. 31, 2023
Portfolio Holdings for ARCH Venture Management
ARCH Venture Management holds 7 positions in its portfolio as reported in the December 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Revolution Medicines (RVMD) | 56.7 | $93M | 3.2M | 28.68 | |
| Verve Therapeutics (VERV) | 17.1 | $28M | 2.0M | 13.94 | |
| Erasca (ERAS) | 14.4 | $24M | 11M | 2.13 | |
| Denali Therapeutics (DNLI) | 5.0 | $8.2M | 381k | 21.46 | |
| Gossamer Bio (GOSS) | 4.5 | $7.4M | 8.1M | 0.91 | |
| Unity Biotechnology (UBX) | 1.2 | $1.9M | 1.0M | 1.93 | |
| Singular Genomics Systems In | 1.1 | $1.7M | 3.8M | 0.46 |
